Key facts
- Notable investors include Vision Plus Capital, Shanghai Pudong Venture Capital, Xihu VC.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for AIxBIO
- ·The full record, as it builds
Funding rounds
No funding rounds for AIxBIO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AIxBIO
Developer of fermentation technology designed for biological engineering. The company's products mainly focus on intelligent fermentation technology platforms, It is based on mathematical models and artificial intelligence and combines biological and fluid information to realize biomanufacturing from laboratory to mass production quickly and at a low cost, enabling to save a lot of time and resources and optimize production efficiency.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2023
- Website
- aixb.io/
- Ownership
- Privately Held (backing)
AIxBIO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AIxBIO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AIxBIO in its N-PORT filings yet. We sweep new filings monthly.